-transparent.png){kind=logo}
Isolated spinal cords of newborn rats were perfused with artificial cerebrospinal fluid and the effects of substance P and its analogs on the release of endogenous GABA were examined. Application of substance P evoked a dose-dependent release of GABA from spinal cords. The threshold concentration of substance P for induction of a significant increase in the GABA release was 3 microM. The substance P-evoked GABA release was neither blocked by removal of Ca2+ from perfusion medium nor by tetrodotoxin. In contrast, the GABA release evoked by high K+ (90 mM) was abolished in Ca(2+)-free medium, and the GABA release evoked by veratridine (5 microM) was suppressed by tetrodotoxin (1 microM). A GABA uptake inhibitor, cis-4-hydroxynipecotic acid, markedly augmented the GABA release induced by high K+, but not that induced by substance P or veratridine. These results suggest the possibility that a carrier-mediated mechanism might be involved in the GABA release induced by substance P, as well as by veratridine, in the newborn rat spinal cord. Two N-terminal fragments of substance P, substance P free acid and substance P1-10 amide, as well as [D-Arg1,D-Trp7,9,Leu11]substance P (spantide), evoked an increase in the GABA release, whereas substance P1-6, and a C-terminal fragment, substance P5-11 were inactive. Somatostatin and compound 48/80 also evoked a GABA release, which was independent of external Ca2+ and resistant to tetrodotoxin. [D-Pro4,D-Trp7,9,10]substance P4-11 (10-15 microM) inhibited the GABA release evoked by substance P, somatostatin and compound 48/80.(ABSTRACT TRUNCATED AT 250 WORDS)
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
July 1993,
Regulatory peptides,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
November 1976,
Nature,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
December 1998,
British journal of pharmacology,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
September 1995,
Neuroscience,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
May 1980,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
January 1989,
Peptides,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
January 2000,
The European journal of neuroscience,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
January 1974,
Japanese journal of pharmacology,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
March 1996,
European journal of pharmacology,
M Sakuma, and
K Yoshioka, and
H Suzuki, and
M Yanagisawa, and
Y Onishi, and
N Kobayashi, and
M Otsuka
June 1997,
Brain research,
